PennyMac Financial Services, Inc. (FRA:1AC)
79.50
+1.00 (1.27%)
At close: Jul 29, 2025, 10:00 PM CET
Intra-Cellular Therapies Market Cap
FRA:1AC has a market cap or net worth of €4.29 billion as of August 1, 2025. Its market cap has decreased by -11.16% in one year.
Market Cap
4.29B
Enterprise Value
n/a
Revenue
3.04B
Ranking
n/a
PE Ratio
13.04
Stock Price
$79.50
Market Cap Chart
Since May 10, 2013, FRA:1AC's market cap has increased from 168.16M to 4.29B, an increase of 2,452.73%. That is a compound annual growth rate of 30.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 4.21B | -16.74% |
Dec 31, 2024 | 5.06B | 26.69% |
Dec 29, 2023 | 3.99B | 50.33% |
Dec 30, 2022 | 2.66B | -26.69% |
Dec 31, 2021 | 3.62B | -6.80% |
Dec 31, 2020 | 3.89B | 63.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 284.92B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 151.49B |
Allianz SE | 127.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 78.24B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 73.00B |
Deutsche Bank Aktiengesellschaft | 55.70B |